TickerFactsScreenerDevelopers

Lantern Pharma Inc. (LTRN) — Operating Income

Annual figures by fiscal year, from SEC filings.

2021: -$12.59M2022: -$14.43M2023: -$17.88M2024: -$22.22M2025: -$17.98M-$17.98M
2021Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$17.98M+19.1%
2024-$22.22M-24.3%
2023-$17.88M-23.9%
2022-$14.43M-14.6%
2021-$12.59M—